Haemonetics Corp (HAE) stock
HAENYSESurgical & Medical Instruments & ApparatusFiscal year ends April 3
Financials through Q1 FY2027, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3077% above fair value
$122.86+1.94 (+1.60%)
Close on Nov 18, 2026Market cap $5.59BP/E 59.9Yield –
Haemonetics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Haemonetics's free cash flow for the twelve months ending Jun 27, 2026 was $291.22M, up 53.9% year over year. For fiscal 2026 it was $260.44M, up 82.8% from the year before. Over ten years it grew 29.6% a year on average. The highest annual figure on record is $260.44M in fiscal 2026.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 28, 2026 | $260.44M | +82.8% |
| FY2025 | Mar 29, 2025 | $142.45M | -0.8% |
| FY2024 | Mar 30, 2024 | $143.63M | +75.7% |
| FY2023 | Apr 1, 2023 | $81.73M | +7.9% |
| FY2022 | Apr 2, 2022 | $75.75M | +5.6% |
| FY2021 | Apr 3, 2021 | $71.77M | -34.4% |
| FY2020 | Mar 28, 2020 | $109.46M | +171.5% |
| FY2019 | Mar 30, 2019 | $40.32M | -72.3% |
| FY2018 | Mar 31, 2018 | $145.55M | +74.1% |
| FY2017 | Apr 1, 2017 | $83.60M | +329.6% |
| FY2016 | Apr 2, 2016 | $19.46M | +292.5% |
| FY2015 | Mar 28, 2015 | $4.96M | -92.5% |
| FY2014 | Mar 29, 2014 | $65.88M | +187.8% |
| FY2013 | Mar 30, 2013 | $22.89M | -63.2% |
| FY2012 | Mar 31, 2012 | $62.12M | -19.1% |
| FY2011 | Apr 2, 2011 | $76.79M | +3.3% |
| FY2010 | Apr 3, 2010 | $74.36M | +24.0% |
| FY2009 | Mar 28, 2009 | $59.99M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 27, 2026 | $44.42M | +225.6% |
| Q4 FY2026CQ1 2026 | Mar 28, 2026 | $53.28M | -47.2% |
| Q3 FY2026CQ4 2025 | Dec 27, 2025 | $87.22M | +147.6% |
| Q2 FY2026CQ3 2025 | Sep 27, 2025 | $106.31M | +169.9% |
| Q1 FY2026CQ2 2025 | Jun 28, 2025 | $13.64M | – |
| Q4 FY2025CQ1 2025 | Mar 29, 2025 | $100.91M | +75.8% |
| Q3 FY2025CQ4 2024 | Dec 28, 2024 | $35.22M | – |
| Q2 FY2025CQ3 2024 | Sep 28, 2024 | $39.39M | -56.2% |
| Q1 FY2025CQ2 2024 | Jun 29, 2024 | -$33.08M | -390.0% |
| Q4 FY2024CQ1 2024 | Mar 30, 2024 | $57.40M | – |
| Q3 FY2024CQ4 2023 | Dec 30, 2023 | -$15.19M | -131.9% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $90.01M | +76.2% |
| Q1 FY2024CQ2 2023 | Jul 1, 2023 | $11.41M | – |
| Q4 FY2023CQ1 2023 | Apr 1, 2023 | -$13.44M | -140.8% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $47.57M | +33.0% |
| Q2 FY2023CQ3 2022 | Oct 1, 2022 | $51.08M | +125.5% |
| Q1 FY2023CQ2 2022 | Jul 2, 2022 | -$3.47M | – |
| Q4 FY2022CQ1 2022 | Apr 2, 2022 | $32.94M | – |
| Q3 FY2022CQ4 2021 | Jan 1, 2022 | $35.77M | -37.2% |
| Q2 FY2022CQ3 2021 | Oct 2, 2021 | $22.65M | +8.8% |
| Q1 FY2022CQ2 2021 | Jul 3, 2021 | -$15.60M | -479.0% |
| Q4 FY2021CQ1 2021 | Apr 3, 2021 | -$10.09M | -128.2% |
| Q3 FY2021CQ4 2020 | Dec 26, 2020 | $56.92M | -3.4% |
| Q2 FY2021CQ3 2020 | Sep 26, 2020 | $20.82M | +1.9% |
| Q1 FY2021CQ2 2020 | Jun 27, 2020 | $4.12M | – |
| Q4 FY2020CQ1 2020 | Mar 28, 2020 | $35.76M | +416.6% |
| Q3 FY2020CQ4 2019 | Dec 28, 2019 | $58.89M | +103.6% |
| Q2 FY2020CQ3 2019 | Sep 28, 2019 | $20.43M | +130.3% |
| Q1 FY2020CQ2 2019 | Jun 29, 2019 | -$5.62M | – |
| Q4 FY2019CQ1 2019 | Mar 30, 2019 | $6.92M | -82.0% |
| Q3 FY2019CQ4 2018 | Dec 29, 2018 | $28.92M | -25.5% |
| Q2 FY2019CQ3 2018 | Sep 29, 2018 | $8.87M | -79.6% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | -$4.39M | -117.8% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $38.52M | +103.2% |
| Q3 FY2018CQ4 2017 | Dec 30, 2017 | $38.82M | +6.9% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $43.50M | +116.2% |
| Q1 FY2018CQ2 2017 | Jul 1, 2017 | $24.70M | – |
| Q4 FY2017CQ1 2017 | Apr 1, 2017 | $18.96M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $36.31M | – |
| Q2 FY2017CQ3 2016 | Oct 1, 2016 | $20.12M | – |
See a number that looks wrong?